Abstract
Objectives
To compare the sensitivity of Liver Imaging Reporting and Data System (LI-RADS) v2017 for diagnosis of hepatocellular carcinoma (HCC) using multiphasic computed tomography (CT) between patients with and without moderate to severe fatty liver (MSFL).
Methods
This retrospective study included a total of 106 high-risk patients with 112 pathologically proven HCCs who underwent multiphasic CT. Patients were classified as MSFL (24 men, 2 women; mean age, 59.5 years [range, 38–79 years]) and non-MSFL (64 men, 16 women; mean age, 62.9 years [range, 40–89 years]) groups according to unenhanced CT liver and spleen parenchymal attenuation. Two independent radiologists assigned LI-RADS categories and accessed HCC features on CT. Sensitivities for LR-5 assignment and frequencies of HCC features were compared between the two groups.
Results
Sensitivities of LR-5 assignment for diagnosing HCCs were not significantly different between MSFL and non-MSFL groups (65.4% [17/26] vs. 76.7% [66/86] for reviewer 1, p = 0.247; 73.1% [19/26] vs. 76.74% [66/86] for reviewer 2, p = 0.702). No significant differences in the frequencies of arterial hyperenhancement, washout, and capsule were observed between the two groups (96.2% [25/26] vs. 98.8% [85/86], p = 0.412; 80.8% [21/26] vs. 89.5% [77/86], p = 0.308; and 53.8% [14/26] vs. 57% [49/86], p = 0.778, respectively).
Conclusions
LI-RADS v2017 using CT showed comparable sensitivity for diagnosing HCC regardless of MSFL.
Key Points
• Using LI-RADS v2017 with CT, diagnosis of HCC in patients with MSFL showed similar sensitivity to that in patients without MSFL.
• Frequencies of major HCC features (arterial hyperenhancement, washout, and capsule) on CT between the MSFL and non-MSFL groups were not significantly different.
• LI-RADS using CT may be feasible for diagnosing HCC in patients with fatty liver.
Similar content being viewed by others
Abbreviations
- CT:
-
Computed tomography
- HCC:
-
Hepatocellular carcinoma
- HU:
-
Hounsfield units
- ICC:
-
Intraclass correlation coefficient
- LC:
-
Liver cirrhosis
- LI-RADS:
-
Liver Imaging Reporting and Data System
- MSFL:
-
Moderate to severe fatty liver
- NAFLD:
-
Non-alcoholic fatty liver disease
- ROI:
-
Region of interest
- TIV:
-
Tumour in vein
References
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
Schafer DF, Sorrell MF (1999) Hepatocellular carcinoma. Lancet 353:1253–1257
Younossi ZM, Stepanova M, Afendy M et al (2011) Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol 9:524–530. e521
Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221–1231
Baffy G, Brunt EM, Caldwell SH (2012) Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. J Hepatol 56:1384–1391
Boyce CJ, Pickhardt PJ, Kim DH et al (2010) Hepatic steatosis (fatty liver disease) in asymptomatic adults identified by unenhanced low-dose CT. AJR Am J Roentgenol 194:623–628
Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022
European Association For The Study Of The Liver (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions. Hepatology 61:1056–1065
Elsayes KM, Hooker JC, Agrons MM et al (2017) 2017 Version of LI-RADS for CT and MR Imaging: An Update. Radiographics 37:1994–2017
Tang A, Bashir MR, Corwin MT et al (2017) Evidence Supporting LI-RADS Major Features for CT-and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review. Radiology 286:29–48
Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features. Radiology 273:30–50
Yoon JH, Park JW, Lee JM (2016) Noninvasive diagnosis of hepatocellular carcinoma: elaboration on Korean Liver Cancer Study Group-National Cancer Center Korea practice guidelines compared with other guidelines and remaining issues. Korean J Radiol 17:7–24
Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK (2017) Liver imaging reporting and data system v2014 categorisation of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 45:731–740
Zhang YD, Zhu FP, Xu X et al (2016) Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models. J Magn Reson Imaging 43:373–383
Ehman EC, Behr SC, Umetsu SE et al (2016) Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY) 41:963–969
Corwin MT, Fananapazir G, Jin M, Lamba R, Bashir MR (2016) Differences in liver imaging and reporting data system categorisation between MRI and CT. AJR Am J Roentgenol 206:307–312
Pickhardt PJ, Park SH, Hahn L, Lee SG, Bae KT, Yu ES (2012) Specificity of unenhanced CT for non-invasive diagnosis of hepatic steatosis: implications for the investigation of the natural history of incidental steatosis. Eur Radiol 22:1075–1082
Iannaccone R, Piacentini F, Murakami T et al (2007) Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243:422–430
Fraum TJ, Tsai R, Rohe E et al (2017) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology 286:158–172
Marrero JA, Hussain HK, Nghiem HV, Umar R, Fontana RJ, Lok AS (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with an arterially-enhancing liver mass. Liver Transpl 11:281–289
Grazioli L, Olivetti L, Fugazzola C et al (1999) The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 9:62–67
Bashir MR, Huang R, Mayes N et al (2015) Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications. J Magn Reson Imaging 42:305–314
Funding
This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.
This work was supported by the Soonchunhyang University Research Fund.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Guarantor
The specific guarantor of this publication is Sung Shick Jou, the head of the Radiology Department of Soonchunhyang University College of Medicine, Cheonan Hospital, Republic of Korea
Conflict of interest
The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
Statistics and biometry
Suyeon Park and Nam Hun Heo kindly provided statistical advice for this manuscript.
Informed consent
Written informed consent was waived by the Institutional Review Board because of the retrospective nature of the study.
Ethical approval
Institutional Review Board approval was obtained.
Methodology
Retrospective, observational, performed at one institution
Rights and permissions
About this article
Cite this article
Kim, S.S., Hwang, J.A., Shin, H.C. et al. LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?. Eur Radiol 29, 186–194 (2019). https://doi.org/10.1007/s00330-018-5657-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-018-5657-y